QMSMEDI150.00

QMS Medical Allied Services Limited

· Pharma & Health
₹ CroreMcap ₹290 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation3.83.9
+ Finance Costs0.05.9
+ Other Non-cash Items-0.30.0
+ Other — Cash Effects are Investing / Financing0.0-1.1
Changes in Working Capital
+ Inventories-1.7-6.6
+ Trade Receivables-0.0-9.4
+ Other Current Assets-7.0-3.6
+ Trade Payables-4.81.5
+ Other Current Liabilities17.118.3
+ Provisions0.0-1.3
Total Working Capital Changes3.5-1.1
Cash from Operating Activities
Profit Before Tax (per I/S)18.716.426.3
+ Total Adjustments (incl. Working Capital)7.17.7
Cash from Operations (pre-tax)25.724.1
+ Other Inflows / (Outflows) — Operating0.00.0
+ Income Taxes Paid5.64.7
Cash from Operating — before Extraordinary Items20.119.4
Cash from Operating Activities20.119.4
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.05.8
+ Acq of Intangible Assets48.30.0
+ Disp of Fixed Assets0.10.0
+ Purchase of Investments (Equity / Debt)0.014.5
+ Payments on Futures / Forwards / Options / Swaps3.40.0
+ Interest Received — Investing2.71.1
+ Other Inflows / (Outflows) — Investing3.5-1.1
Cash from Investing — before Extraordinary Items-45.5-20.4
Cash from Investing Activities-45.5-20.4
Cash from Financing Activities
+ Proceeds from Issue of Shares (unclassified)0.010.4
+ Proceeds from Borrowings44.40.0
+ Repayment of Borrowings15.42.5
+ Interest Paid2.35.9
+ Dividends Paid0.90.9
Cash from Financing — before Extraordinary Items25.91.1
Cash from Financing Activities25.91.1
Net Changes in Cash (pre-FX)0.50.1
Net Changes in Cash0.50.1
Reference Items
EBITDA25.425.940.9
EBITDA Margin %16.2914.9715.33
Free Cash Flow (CFO − Capex)-28.213.713.7
Free Cash Flow per Basic Share-14.597.067.06
Price to Free Cash Flow21.25
Cash Flow to Net Income1.471.63
Cash Paid for Taxes5.64.7
Cash Paid for Interest2.35.9
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.